Because little evidence of adverse effects is included in the guidelines for the pharmacological treatment of many diseases, it causes “Pregabalinophobia”

Toda, Katsuhiro

Volume: 37 Issue: 2 Year: 2025

37/2Current Issue Archive Popular Articles Ahead of Print

Author Contribution Form

ICMJE COI Form

PubMed

Medline

Emerging Sources Citation Index

Quick Search

CLOCKSS system has permission to ingest, preserve, and serve this Archival Unit

Because little evidence of adverse effects is included in the guidelines for the pharmacological treatment of many diseases, it causes “Pregabalinophobia” [Ağrı]

Ağrı. 2023; 35(3): 181-182 | DOI: 10.14744/agri.2022.79803

Because little evidence of adverse effects is included in the guidelines for the pharmacological treatment of many diseases, it causes “Pregabalinophobia”

Katsuhiro Toda
Department of Orthopedic Surgery, Hiroshima Clinic, Hiroshima, Japan

Keywords: Pregabalinophobia, pharmacological treatment, adverse effect, pregabalin, guidelines, fibromyalgia

Birçok hastalığın farmakolojik tedavisine yönelik kılavuzlarda yan etkilere ilişkin çok az kanıt yer aldığından, “Pregabalinofobi “ye neden olmaktadır

Katsuhiro Toda
Hiroşima Kliniği, Ortopedik Cerrahi Bölümü, Hiroşima, Japonya

Corresponding Author: Katsuhiro Toda, Japan
Manuscript Language: English

CITE

Full Text PDF Download citation RIS EndNote BibTex Medlars Procite Reference Manager Send email to author Similar articles PubMed Google Scholar